miR-590-3p Alleviates diabetic peripheral neuropathic pain by targeting RAP1A and suppressing infiltration by the T cells.
CONCLUSION: miR-590-3p ameliorates DPNP via targeting RAP1A and inhibiting T cells infiltration, indicating that exogenous miR-590-3p may be a potential candidate for clinical treatment of DPNP.
PMID: 33332780 [PubMed - as supplied by publisher]
Source: Acta Biochim Pol - Category: Biochemistry Authors: Wu Y, Gu Y, Shi B Tags: Acta Biochim Pol Source Type: research
More News: Biochemistry | Brain | Diabetes | Endocrinology | Genetics | Neurology | Pain | Peripheral Neuropathy | Study